University of California San Francisco
Give to UCSF
UCSF researchers are leading several initiatives that aim to see how dozens of seemingly unrelated genes and proteins involved in a disease are in fact all part the same interconnected biological pathway.
Scientists from two U.S. national laboratories, industry, and academia on Oct. 27 launched an unprecedented effort to transform the way cancer drugs are discovered.
UCSF has ranked in the top 10 for seven specialties in 2017 Best Global Universities rankings released Tuesday by U.S. News & World Report.
UCSF researchers have identified a molecular signature in tissue adjacent to tumors in eight of the most common cancers that suggests they are all using the same mechanism to remodel normal tissue and spread.
The NCI has announced that UCSF will host one of five new Cancer Drug Resistance and Sensitivity Centers being set up around the U.S. through funding from the 21st Century Cures Act of 2016.
Researchers at UC San Francisco, the University of North Carolina-Chapel Hill, and Stanford University report a major step toward designing more powerful psychiatric drugs with fewer side effects.
Encellin obtained exclusive rights from UCSF for a proprietary cell encapsulation technology aimed at improving physicians’ ability to perform cell transplants without the need for immunosuppressive drugs.
UCSF scientists have successfully completed a Phase II clinical trial showing that an FDA-approved antihistamine restores nervous system function in patients with chronic MS.
UCSF researchers have discovered that two molecular partners interact at synapses to maintain stable neuronal function.
Newly developed microscopy techniques have allowed UC San Francisco researchers to observe white blood cells in action in unprecedented detail.
Research team led by University of California scientists has used a modified version of the gene-editing technique CRISPR to find enhancers by prompting them into action.
A new study by UCSF researchers raises a red flag against adding antibiotics when growing cells in labs, finding that it can induce unintentional genetic changes in the cells and distort test results.
Two UCSF School of Pharmacy faculty members, whose research and clinical practice have focused on the identification and minimization of side effects, have pinpointed routes for improvement.
UCSF neuroscientists answered questions about a molecule that reverses severe memory and learning impairments in mice with traumatic brain injury.
